Literature DB >> 2109016

An enzyme-linked immunosorbent assay for the determination of human IgG subclass antibodies directed against Branhamella catarrhalis.

D Goldblatt1, N D Seymour, R J Levinsky, M W Turner.   

Abstract

An ELISA procedure to determine the distribution of human IgG subclass antibodies directed against the gram-negative bacterium Branhamella catarrhalis has been developed using commercially available monoclonal anti-IgG subclass antibodies. Using whole bacteria as coating antigen the specificity of the assay was determined and showed minimal cross-reactivity with a range of other bacteria. Estimations of IgG1, IgG2, IgG3, IgG4 and total IgG antibodies directed against this antigen were performed. All normal adult sera tested had measurable antibody levels of specific IgG1, IgG2, IgG3 and total IgG. Specific IgG4 was undetectable in the majority of adult sera. These assays will be of value for investigation of both children and adults with suspected immunodeficiency and recurrent upper respiratory tract infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109016     DOI: 10.1016/0022-1759(90)90213-f

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria.

Authors:  I Jönsson; T Holme; A Krook; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

Review 2.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  A protective epitope of Moraxella catarrhalis is encoded by two different genes.

Authors:  C Aebi; I Maciver; J L Latimer; L D Cope; M K Stevens; S E Thomas; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

6.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

7.  Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay.

Authors:  T Ejlertsen; E Thisted; P A Ostergaard; J Renneberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

8.  Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.

Authors:  I Jönsson; T Holme; A Krook; M Rahman; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

9.  Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E.

Authors:  C Aebi; E R Lafontaine; L D Cope; J L Latimer; S L Lumbley; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.